David Abrams - Abrams Capital Management,
Holding/activity history for Akebia Therapeutics Inc (AKBA)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2020 Q4 | 0 | 0.00 | Sell 100.00% | 0.45 | SEC | ||
| 2020 Q3 | 5,656,462 | 0.45 | $2.51 | $14,198,000 | SEC | ||
| 2020 Q2 | 5,656,462 | 2.48 | $13.58 | $76,815,000 | SEC | ||
| 2020 Q1 | 5,656,462 | 1.69 | $7.58 | $42,876,000 | SEC | ||
| 2019 Q4 | 5,656,462 | 1.11 | $6.32 | $35,749,000 | SEC | ||
| 2019 Q3 | 5,656,462 | 0.62 | $3.92 | $22,173,000 | SEC | ||
| 2019 Q2 | 5,656,462 | 0.74 | $4.84 | $27,377,000 | SEC | ||
| 2019 Q1 | 5,656,462 | 1.30 | $8.19 | $46,326,000 | SEC | ||
| 2018 Q4 | 5,656,462 | 1.29 | Add 405.36% | 1.03 | $5.53 | $31,280,000 | SEC |
| 2018 Q3 | 1,119,286 | 0.26 | Buy | 0.26 | $8.83 | $9,883,000 | SEC |